Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000176624 | SCV000228312 | likely benign | not specified | 2014-11-19 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000504628 | SCV000464418 | uncertain significance | Retinitis pigmentosa | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Counsyl | RCV000665978 | SCV000790202 | likely benign | Retinitis pigmentosa 25 | 2017-03-17 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000963176 | SCV001110313 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000665978 | SCV001159163 | likely benign | Retinitis pigmentosa 25 | 2020-04-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000963176 | SCV001865806 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24265693) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000176624 | SCV002555712 | likely benign | not specified | 2022-06-07 | criteria provided, single submitter | clinical testing | Variant summary: EYS c.5510G>C (p.Trp1837Ser) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.004 in 153716 control chromosomes in the gnomAD database, including 6 homozygotes. The observed variant frequency is approximately 1.17 fold of the estimated maximal expected allele frequency for a pathogenic variant in EYS causing Retinitis Pigmentosa phenotype (0.0034), strongly suggesting that the variant is benign. c.5510G>C has been reported in the literature in individuals affected with Retinitis Pigmentosa, however it is often observed in the heterozygous state without a variant reported in the second allele and in several studies the variant was considered to be a polymorphism (example Audo_2010, Eisenberger_2013, Wang_2014, Perez-Carro_2016). These reports do not provide unequivocal conclusions about association of the variant with Retinitis Pigmentosa. Six ClinVar submitters have provided assessments for this variant after 2014. Two classified the variant as benign, three as likely benign, and one as VUS. Based on the evidence outlined above, the variant was classified as likely benign. |
Ce |
RCV000963176 | SCV003917074 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | EYS: BP4, BS2 |
NIHR Bioresource Rare Diseases, |
RCV000504628 | SCV000599155 | likely benign | Retinitis pigmentosa | 2015-01-01 | no assertion criteria provided | research | |
Natera, |
RCV000504628 | SCV001459613 | benign | Retinitis pigmentosa | 2020-01-10 | no assertion criteria provided | clinical testing |